Susan L Ford Selected Research

Gastroenteritis

1/2014

Pharmacokinetics, safety and antiviral activity of fosamprenavir/ritonavir-containing regimens in HIV-infected children aged 4 weeks to 2 years-48-week study data.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susan L Ford Research Topics

Disease

14	Infections 01/2023 - 04/2007
6	Injection Site Reaction 12/2023 - 12/2014
5	Pain (Aches) 12/2023 - 01/2017
5	HIV Infections (HIV Infection) 01/2023 - 11/2013
2	Hypersensitivity (Allergy) 04/2024 - 01/2014
2	Diarrhea 01/2014 - 01/2014
1	Urticaria (Hives) 04/2024
1	Fatigue 12/2023
1	Otitis Media 01/2014
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2014
1	Vomiting 01/2014
1	Cough 01/2014
1	Gastroenteritis 01/2014
1	Bartonella Infections (Bartonellosis) 10/2008
1	Tuberculosis (Tuberculoses) 02/2008

Drug/Important Bio-Agent (IBA)

15	cabotegravirIBA 12/2023 - 07/2015
10	Rilpivirine (TMC-278)IBA 04/2024 - 11/2013
2	Integrase InhibitorsIBA 01/2019 - 01/2019
2	TabletsIBA 01/2019 - 01/2016
2	Reverse Transcriptase InhibitorsIBA 10/2015 - 11/2013
1	RacivirIBA 01/2023
1	dolutegravirIBA 01/2020
1	lamivudine drug combination abacavir FDA Link 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2017
1	Human immunodeficiency virus 1 p31 integrase proteinIBA 01/2017
1	HIV IntegraseIBA 01/2016
1	NucleosidesIBA 10/2015
1	RNA (Ribonucleic Acid)IBA 01/2014
1	abacavir (Ziagen)FDA Link 01/2014
1	isinglassIBA 10/2008
1	Rifabutin (Ansamycin)FDA Link 02/2008
1	brecanavirIBA 04/2007
1	Protease Inhibitors (Protease Inhibitor)IBA 04/2007

Therapy/Procedure

9	Injections 01/2023 - 12/2014
3	Therapeutics 01/2020 - 12/2014
1	Contraindications 12/2023